IL-33 deficiency slows cancer growth but does not protect against cisplatin-induced AKI in mice with cancerKameswaran Ravichandran, Charles L. Edelstein, Abdullah Özkök et al.|American Journal of Physiology-Renal Physiology|2017Cited by 14
The effect of MEK1/2 inhibitors on cisplatin-induced acute kidney injury (AKI) and cancer growth in miceCarolyn Nicole Brown, Charles L. Edelstein, Daniel Atwood et al.|Cellular Signalling|2020Cited by 13